The Department of Hemato-Oncology and Bone Marrow Transplantation (BMT) provides life-saving, comprehensive care for all disorders and cancers of the blood, bone marrow, and lymphatic system. Our specialized program integrates advanced drug therapies, including Immunotherapy, Targeted Therapy, and CAR T-cell therapy, with our state-of-the-art Bone Marrow Transplant Unit. Led by expert hematologists and transplant physicians, we offer personalized treatment for complex blood malignancies and non-cancerous blood disorders, adhering to global standards like those set by ASCO and NCCN.
The Hemato-Oncology and BMT department combines the expertise of Hematology (the study of blood disorders) and Oncology (the study of cancer) to manage diseases that originate in the bone marrow, blood, or lymph nodes. Our scope encompasses both cancerous (malignant) and non-cancerous (benign) conditions.
We specialize in the diagnosis and treatment of complex blood cancers, including Leukemia (Acute and Chronic), Lymphoma (Hodgkin's and Non-Hodgkin's), and Multiple Myeloma.
We provide expert management for severe conditions such as Thalassemia, Sickle Cell Disease, Severe Aplastic Anemia, and congenital immune deficiencies, often offering a Bone Marrow Transplant as a potential cure.
Our team is engaged in translational research, ensuring patients benefit from the latest developments in cellular therapy and precision diagnostics to optimize outcomes and reduce complications.
Our services are centred around delivering highly specialized systemic treatments and offering the complete spectrum of Stem Cell Transplantation options.
The Procedure: Hematopoietic Stem Cell Transplantation is a potentially curative treatment that replaces a patient's diseased or damaged bone marrow with healthy blood-forming stem cells. The patient first undergoes a Conditioning Regimen—high-dose chemotherapy (and sometimes radiotherapy)—to eradicate the malignant cells and suppress the immune system before the new stem cells are infused.
Replacing the Marrow: For life-threatening blood diseases, we use intense therapy to clear the faulty bone marrow, followed by a simple blood-like infusion of healthy stem cells (the "transplant") that grow into new, healthy blood cells.
We perform Autologous (using the patient's own cells), Allogeneic (using cells from a matched related or unrelated donor), Haploidentical (using a half-matched family donor), and Umbilical Cord Blood transplants.
Finding the Best Match: We explore all options—from using your own cells (Autologous) to using a carefully matched donor (a sibling, or an unrelated donor, or a "half-match" family member) to ensure the highest chance of success.
Includes tailored chemotherapy protocols, Targeted Therapy (drugs that block specific pathways), and novel Immunotherapy agents (e.g., CAR T-cell therapy and checkpoint inhibitors) based on precise molecular genetic profiling of the disease.
Smart Medications: We look deep into your cancer's DNA to choose drugs—including cutting-edge cell-based therapies—that target the disease with maximum power and minimum impact on your healthy body cells.
Our Bone Marrow Transplant Unit is a sterile environment, featuring positive-pressure, HEPA-filtered rooms that provide strict protective isolation. This infrastructure is crucial for minimizing the risk of infection during the critical, high-risk recovery phase following the transplant.
Our in-house diagnostics include sophisticated molecular pathology, flow cytometry, and specialized hematopathology, allowing for rapid and highly accurate diagnosis and monitoring of residual disease.
Our transplant physicians and clinical hematologists are fellowship-trained and specialize exclusively in blood disorders, providing deep expertise recognized globally.
Every step of the transplant process, from donor matching and stem cell collection (via our in-house Apheresis Unit) to post-engraftment follow-up, strictly adheres to rigorous international protocols for patient safety and transplant immunology.
Recognizing the intensity of BMT, our department provides fully integrated supportive care, including dedicated Infection Control Protocols, specialized Nutrition Counseling, Psycho-oncology, and Palliative Care to manage symptoms and ensure the emotional well-being of both the patient and the family throughout the long recovery journey.
MBBS (2012), MD - General Medicine (2018), DM - Clinical Hematology (2021)
Fellowship: PDCC - Hemato Oncology (2018)
Consultant
Clinical Hemato Oncology & BMT
MBBS (2014), MD-General Medicine (2019), DM-Clinical Haematology (2023)
Fellowship: Fellowship in Leukemia and BMT, Vancouver, Canada
Consultant
Hemato Oncology